Sun Pharm Inds Company Profile

✉ Email this page to a colleague

SUN PHARM INDS has two hundred and twenty-seven approved drugs.

There are six US patents protecting SUN PHARM INDS drugs. There are eleven tentative approvals on SUN PHARM INDS drugs.

There are twenty-six patent family members on SUN PHARM INDS drugs in thirteen countries and two hundred and nineteen supplementary protection certificates in sixteen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Ltd	AMOXICILLIN	amoxicillin	CAPSULE;ORAL	065016-002	Apr 8, 1999		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Inc	HALOG	halcinonide	OINTMENT;TOPICAL	017824-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Inc	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	090529-001	Dec 30, 2011		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Inc	LEQSELVI	deuruxolitinib phosphate	TABLET;ORAL	217900-001	Jul 25, 2024		RX	Yes	Yes	10,561,659	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-003	May 25, 2012	7,435,427	⤷ Sign Up
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-005	Aug 15, 2014	8,952,064	⤷ Sign Up
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-005	Aug 15, 2014	8,367,102	⤷ Sign Up
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-001	May 25, 2012	7,435,427	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-01-07
➤ Subscribe	Capsules	35 mg	➤ Subscribe	2015-11-25
➤ Subscribe	Capsules	30 mg and 40 mg	➤ Subscribe	2012-12-31
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-06-19
➤ Subscribe	Capsules	25 mg	➤ Subscribe	2016-05-16

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0565634	06C0030	France	⤷ Sign Up	PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607
0347066	2002C/039	Belgium	⤷ Sign Up	PRODUCT NAME: ESCITALOPRAM. OXALAT. (INN) ESCITALOPRAM; NATL. REGISTRATION NO/DATE: 7004 IE10 F 3 20020729; FIRST REGISTRATION: SE 17084 20011207
3225249	2019C/520	Belgium	⤷ Sign Up	PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513
1412357	132008901682802	Italy	⤷ Sign Up	PRODUCT NAME: SITAGLIPTIN/METFORMINA CLORIDRATO(JANUMET, VELMETIA, EFFICIB); AUTHORISATION NUMBER(S) AND DATE(S): JANUMET:EU/1/08/455/001... 014; VELMETIA:EU/1/08/456/001...014;EFFICIB: EU/1/08/457/001....014, 20080716;58450-01;58450-02; 58450-03, 20080408
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.